The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story

Dainippon Sumitomo is a top pharmaceutical company based in Osaka, Japan Read the full story

Dainippon Sumitomo, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years Read the full story

Edison Pharmaceuticals pharma partners with Dainippon Sumitomo, a big pharma company in a  research/development and commercialization agreement with  for the development of EPI-743 and EPI-589 in Japan. Read the full story

This report provides all the information you require to better understand Dainippon Sumitomo and its partnering interests and activities over the past seven years. Read the full story

Boston Biomedical is a company with a focus on targeted cancer stem cells. This focus attracted the attention of Dainippon Sumitomo who is paying up to $2.63 billion to secure the company and more importantly rights to its two lead compounds BBI608 and BBI503 Read the full story

Dainippon Sumitomo Pharma announced that the company has reached an agreement with Boston Biomedical on the acquisition of BBI by DSP. Read the full story

The start of 2011 has seen some significant deal activity involving Bigpharma in China. Read the full story

Welcome to the April 2011 edition of Current Agreements Deals Update. Read the full story

Codexis, Inc. has announced the company's first biocatalysis collaboration in Japan, with Dainippon Sumitomo Pharma Co., one of the ten largest Japanese pharmaceutical manufacturers. Read the full story